V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20214586 | 20179869 | 1.54 | 81 | Palliative (P) | 2022-03-27 | 2022-04-10 | Capecitabine (14 day) + Irinotecan | null | N | CAPECITABINE + IRINOTECAN | 101070019 |
| 20214619 | 20179870 | 1.79 | 82.8 | Palliative (P) | 2018-01-14 | 2018-01-24 | Capecitabine (21 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100602166 |
| 20214624 | 20179871 | 1.69 | 72.58 | null | 2020-09-09 | 2020-09-16 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100666496 |
| 20214655 | 20179872 | 1.77 | 60 | null | 2020-09-11 | 2020-09-11 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 101085675 |
| 20214659 | 20179873 | 1.57 | 66 | null | 2020-08-08 | 2020-11-29 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100013801 |
| 20214747 | 20179874 | null | 63.2 | Palliative (P) | 2016-07-29 | 2016-07-29 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100230578 |
| 20214753 | 20179875 | 1.54 | 59.1 | null | 2017-03-15 | 2017-07-25 | CISPLATIN + GEMCITABINE | 02 | null | CISPLATIN + GEMCITABINE | 101057540 |
| 20214772 | 20179876 | 1.79 | 98.3 | null | 2021-09-17 | 2021-10-09 | CAPECITABINE + IRINOTECAN | 02 | null | CAPECITABINE + IRINOTECAN | 100270949 |
| 20214824 | 20179879 | 1.67 | 74.7 | null | 2022-04-22 | 2022-05-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | CISPLATIN + GEMCITABINE | 101510025 |
| 20214835 | 20179880 | 1.78 | 99.9 | Palliative (P) | 2019-11-26 | 2019-12-09 | CISPLATIN + GEMCITABINE | 02 | Y | CISPLATIN + GEMCITABINE | 101479784 |
| 20214847 | 20179881 | 1.72 | 81.4 | null | 2019-11-07 | 2019-11-21 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 101719580 |
| 20214891 | 20179882 | 1.74 | 76.9 | Palliative (P) | 2020-06-23 | 2020-07-09 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 101751699 |
| 20214893 | 20179883 | 1.54 | 67 | Palliative (P) | 2017-03-20 | 2017-04-10 | Capecitabine (14 day) + Irinotecan | 02 | N | CAPECITABINE + IRINOTECAN | 100347945 |
| 20214909 | 20179884 | 1.67 | 42.45 | null | 2018-09-21 | 2018-09-21 | Capecitabine (21 day) + Irinotecan | 02 | null | CAPECITABINE + IRINOTECAN | 100769305 |
| 20214976 | 20179885 | 1.67 | 61 | null | 2020-10-03 | 2021-03-01 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN + GEMCITABINE | 100942694 |
| 20214985 | 20179886 | 1.67 | 66.6 | Palliative (P) | 2022-01-16 | 2022-01-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101837086 |
| 20214995 | 20179887 | 1.8 | 65.5 | Palliative (P) | 2018-10-05 | 2018-12-06 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101342111 |
| 20215020 | 20179888 | 1.69 | 102.6 | Adjuvant (A) | 2021-11-21 | 2021-11-22 | Docetaxel | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101439653 |
| 20215022 | 20179889 | 1.66 | 65.9 | null | 2020-08-06 | 2021-01-01 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100813707 |
| 20215076 | 20179891 | 1.63 | 70.7 | Palliative (P) | 2022-04-14 | 2022-04-18 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100048467 |
| 20215084 | 20179892 | 1.66 | 54 | 03 | 2020-10-14 | 2020-10-19 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100017471 |
| 20215159 | 20179894 | 1.7 | 51.7 | Palliative (P) | 2020-03-30 | 2020-04-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101172881 |
| 20215169 | 20179895 | 1.78 | 64.6 | Palliative (P) | 2017-12-08 | 2018-03-18 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100785299 |
| 20215211 | 20179896 | 1.74 | 78.15 | Adjuvant (A) | 2020-09-19 | 2021-01-13 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100797482 |
| 20215217 | 20179897 | 1.46 | 100.9 | Palliative (P) | 2019-03-24 | 2019-04-07 | Docetaxel | 02 | N | DOCETAXEL | 101077415 |
| 20215385 | 20179899 | 1.67 | 83.4 | Palliative (P) | 2019-11-27 | 2019-12-26 | Docetaxel | 02 | N | DOCETAXEL | 100386693 |
| 20215415 | 20179900 | 1.59 | 61 | Palliative (P) | null | null | Gemcitabine + Capecitabine | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100805659 |
| 20215420 | 20179901 | 1.63 | 70.3 | Palliative (P) | 2017-03-26 | 2018-01-04 | Docetaxel | 02 | N | DOCETAXEL | 101365679 |
| 20215433 | 20179902 | 1.76 | 116 | null | 2019-10-06 | 2019-11-03 | Docetaxel | 02 | null | DOCETAXEL | 100254615 |
| 20215475 | 20179903 | 1.67 | 61.6 | Palliative (P) | 2021-08-12 | 2021-08-13 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101253268 |
| 20215534 | 20179904 | 1.75 | 57.7 | Palliative (P) | 2020-12-08 | 2020-12-26 | Docetaxel | 02 | N | DOCETAXEL | 100896720 |
| 20215544 | 20179905 | 1.81 | 49.5 | null | 2019-03-24 | 2019-04-15 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100339859 |
| 20215554 | 20179906 | 1.63 | 45 | Palliative (P) | 2020-02-29 | 2020-06-25 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100541872 |
| 20215581 | 20179907 | 1.69 | 86 | Palliative (P) | 2019-03-21 | 2019-03-28 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101369155 |
| 20215597 | 20179908 | 1.7 | 90.6 | null | 2017-03-08 | 2017-03-15 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101181409 |
| 20215620 | 20179909 | 1.59 | 70 | Palliative (P) | 2021-11-02 | 2021-11-15 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100499947 |
| 20215623 | 20179910 | 1.6 | 73.9 | Palliative (P) | 2020-03-15 | 2020-03-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100882737 |
| 20215633 | 20179911 | 1.7 | 69.3 | Palliative (P) | 2017-11-16 | 2018-01-20 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100805043 |
| 20215652 | 20179912 | 1.69 | 51 | Palliative (P) | 2019-07-24 | 2020-02-28 | Docetaxel 75mg/m2 (21 day) | 02 | Y | DOCETAXEL | 100014194 |
| 20215655 | 20179913 | 1.63 | 89 | Palliative (P) | 2021-08-06 | 2021-10-17 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100459339 |
| 20215665 | 20179914 | 1.58 | 87 | null | 2018-07-17 | 2018-08-08 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 101029366 |
| 20215689 | 20179915 | 1.75 | 62.8 | Palliative (P) | 2022-03-05 | 2022-04-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100573998 |
| 20215694 | 20179916 | 1.83 | 84 | Palliative (P) | 2022-05-22 | 2022-05-22 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101437009 |
| 20215709 | 20179917 | 1.93 | 80.3 | Palliative (P) | 2021-08-20 | 2021-09-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100495429 |
| 20215714 | 20179918 | 1.84 | 73.8 | Palliative (P) | 2020-02-25 | 2020-03-09 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100398081 |
| 20215740 | 20179919 | 1.52 | 77.45 | Palliative (P) | 2019-04-09 | 2021-07-02 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101858357 |
| 20215753 | 20179920 | 1.85 | 86 | Palliative (P) | 2021-10-06 | 2021-12-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100945170 |
| 20215756 | 20179921 | 1.77 | 78.2 | null | 2020-12-02 | 2020-12-19 | Trastuzumab 21 day maintenance | 02 | null | TRASTUZUMAB | 100675504 |
| 20215775 | 20179922 | 1.44 | 63.6 | Palliative (P) | null | 2021-04-27 | Capecitabine + Cisplatin | N | N | CAPECITABINE + CISPLATIN | 101280717 |
| 20215776 | 20179923 | 1.59 | 85.3 | null | 2020-05-02 | 2020-05-09 | CETUXIMAB | 02 | null | CETUXIMAB | 101590620 |